高雄市生物科技發展協會|http://www.khba.org.tw
會員登入
記住帳號 自動登入
會員名錄
各式辦法
下載專區
留言板
您目前的位置:首頁 / 活動與新訊
Gut microbiome plays a role in immune response to mRNA COVID vaccines
活動日期:2024.01.23
2024.01.23  

Gut microbiome plays a role in immune response to mRNA COVID vaccines

https://reurl.cc/v0anlk

Jan 4 2024Karolinska Institutet

Researchers from Karolinska Institutet in Sweden have discovered that the gut microbiome can influence how well people respond to mRNA COVID vaccines. The study, published in the journal npj Biofilms and Microbiomes, suggests that certain bacteria in the gut can enhance the immune response to the vaccine, whereas other bacteria may weaken it.

The gut microbiome is the collection of microorganisms that live in our digestive tract. It plays an important role in many aspects of our health, such as digestion, metabolism, and immunity. The researchers wanted to find out if the gut microbiome also affects the response to mRNA COVID vaccines. To do this, the researchers collected stool samples from 68 people living with HIV and 75 healthy individuals before their first mRNA COVID vaccine dose.

The researchers analysed the microbiome composition using a technique called 16S rRNA sequencing, which identifies the types and relative abundance of bacteria in the samples. They also measured the levels of antibodies and immune cells that were produced after the vaccination.

We correlated the microbial composition with immune responses and patient characteristics. This comprehensive analysis included age, gender, body mass index and clinical factors for people living with HIV, aiming to understand the complex relationship between gut microbes and vaccine efficacy."

Piotr Nowak, principal investigator, senior physician and associate professor at Karolinska Institutet's Department of Medicine, Huddinge

The results showed that the initial makeup of the gut microbiome could predict the immune response to the vaccine in both groups. They found that a less diverse gut microbiome was associated with a stronger vaccine response, marked by higher levels of spike protein antibodies and spike specific CD4 T-cells. These are key components of the immune system that help to neutralize the virus and prevent severe infection.

The researchers also identified specific bacteria that were linked with better or worse vaccine responses. For example, they found that Lactobacillus, Bacteroides, and Lachnospira were associated with higher antibody and immune cell levels, while Cloacibacillus was associated with lower antibody levels. They also found that Bifidobacterium and Faecalibacterium were microbial markers of individuals with higher antibody levels.

Omics eBook Compilation of the top interviews, articles, and news in the last year.Download the latest edition

According to the researchers, the study highlights the significant role of the gut microbiome in the effectiveness of mRNA COVID vaccines. The findings could lead to developing microbiota-focused treatments to enhance vaccine responses, especially in groups that may have weaker responses, such as the elderly or immunocompromised individuals. The potential strategies could include changing the diet or taking probiotics to improve the gut microbiome and immunity, the researchers suggest.

The study was conducted in collaboration with the Karolinska University Hospital, and SciLifeLab National Genomics Infrastructure in Stockholm, Sweden. The research was funded by Region Stockholm, the Swedish Research Council, and Physicians Against AIDS.

Source:

Karolinska Institutet

Journal reference:

Ray, S., et al. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomesdoi.org/10.1038/s41522-023-00461-w.

共有314筆資料 頁數: 第7頁(共16頁)
編號 標題 新增日期
1 《醫學研究》免疫系統失衡 長庚研究找出關鍵 2016.11.11
2 懷特 新藥研發一條龍 2016.11.09
3 樹王生技 牛樟芝技術大突破 2016.11.03
4 樟芝菌萃取「安綽醣」 教授獲專利 2016.10.20
5 研究新革命!日本創全球首例 用老鼠iPS細胞培育卵子 2016.10.19
6 生技新藥條例 擴大獎勵 2016.10.17
7 台微體癌症用藥 台美兩地申請臨床試驗 2016.09.02
8 302件新藥試驗 治癌占75% 2016.08.11
9 黃斑部病變合併療法 眼睛少挨好幾針 2016.08.04
10 中原團隊研究證實 靈芝阻止PM2.5從肺部進入血液循環 2016.06.24
11 抗癌藥有望! 國衛院找到全新「癌症抑制基因」DKK2 2016.06.16
12 新藥事法釋利多 造福生技業 2016.02.01
13 藥物試驗出人命 法出現首例 2016.01.19
14 台大、中研院破解細菌存活30億年之謎 2015.12.18
15 以價制量 高藥價時代來臨 2015.11.23
16 懷特新藥PG2 驚豔國際 2015.11.04
17 生技藥品主導 醫藥創新世代來臨 2015.10.13
18 浩鼎新藥授權 入帳近億 2015.10.05
19 整合健康科技產業投資說明會 (2015年10月15日(星期四)/10:00AM.. 2015.10.02
20 癌症治療新趨勢 餓死癌細胞 2015.10.02
上一頁  1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16  下一頁
版權所有©2006 高雄市生物科技發展協會 所有文字、資料禁止轉用
地址:高雄市中正一路120號14樓之3 TEL:(07)591-9569 / FAX:(07)591-9018 / e-mail: khba.tw@gmail.com
累積進站人數:3123224